Tevogen (TVGN) EPS (Basic) Growth (1y) (2023 - 2026)
Tevogen (TVGN) EPS (Basic) Growth (1y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.64 Bn | 130.78 Bn | 2.84 Bn | 7.74% |
| 2 | Regeneron Pharmaceuticals | 85.89 Bn | 77.90 Bn | 3.93 Bn | -4.72% |
| 3 | Argenx Se | 65.11 Bn | 59.93 Bn | 1.37 Bn | 88.81% |
| 4 | Moderna | 55.83 Bn | 50.69 Bn | 52.00 Mn | 7.59% |
| 5 | BeOne Medicines | 42.01 Bn | 36.91 Bn | 1.53 Bn | 143.95% |
| 6 | Alnylam Pharmaceuticals | 31.63 Bn | 28.32 Bn | 992.69 Mn | 322.67% |
| 7 | BioNTech SE | 27.65 Bn | 9.26 Bn | 668.28 Mn | -147.33% |
| 8 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn | 96.41% |
| 9 | Royalty Pharma | 27.30 Bn | 26.47 Bn | - | -16.29% |
| 10 | Tevogen | 25.98 Mn | 25.98 Mn | - | -4,882.50% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.35% |
| Mar 31, 2026 | 50.45% |
| Dec 31, 2025 | 54.76% |
| Sep 30, 2025 | 13.88% |
| Jun 30, 2025 | 22.33% |
| Mar 31, 2025 | -185.06% |
| Dec 31, 2024 | -101.39% |
| Sep 30, 2024 | 89.34% |
| Jun 30, 2024 | -219.54% |
| Mar 31, 2024 | 73.09% |
| Dec 31, 2023 | 68,284.37% |
| Sep 30, 2023 | -3,005.35% |
| Jun 30, 2023 | -956.74% |
| Mar 31, 2023 | 8,252.66% |